January 10, 2025 - 04:00

Fed governor Michelle Bowman expressed her endorsement of a rate cut in December, describing it as the 'last step' in the central bank's ongoing 'policy recalibration.' This statement highlights a cautious approach among Federal Reserve officials regarding future monetary policy decisions.
Bowman's comments come amid a broader discussion within the Fed about the need to balance inflation control with economic growth. As inflationary pressures remain a concern, the central bank is navigating the delicate task of adjusting interest rates without stifling recovery.
Her stance reflects a growing sentiment among policymakers who advocate for careful monitoring of economic indicators before making any further adjustments to rates. The emphasis on caution suggests that while some progress has been made, the path ahead may require additional scrutiny to ensure stability in the financial system. Bowman's remarks reinforce the idea that the Fed is committed to a measured approach in its monetary policy strategy.
March 15, 2026 - 03:23
Audit finds strong oversight at Fort Worth Housing Finance Corp, flags minor control gapsA recent operational audit of the Fort Worth Housing Finance Corporation has concluded that the agency maintains strong overall oversight, though it identified a handful of minor internal control...
March 14, 2026 - 07:39
Nvidia GTC, Macy's earnings, FOMC meeting: What to WatchThe upcoming week presents a critical lineup of events for the financial markets, with major corporate developments and a key Federal Reserve meeting on the calendar. All eyes will be on the...
March 13, 2026 - 20:57
Richard Donoff Encourages Americans to Prioritize Long-Term Financial PreparednessIn a recent address, financial expert Richard Donoff emphasized the critical need for American families to shift their focus toward long-term financial preparedness. He advocates for a proactive...
March 13, 2026 - 04:55
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate UpdateCapricor Therapeutics has announced its financial results for the fourth quarter and full year 2025, alongside significant progress in its lead clinical program. The company`s Biologics License...